Christopher D. Earl
"Christopher D. Earl, PhD is an entrepreneur, investor and non-profit leader with broad experience in science, venture capital, and the management of biotechnology companies and not-for-profit organizations. He serves as Senior Advisor to a leading pharmaceutical company’s corporate venture capital fund, and through Innotrove LLC advises other leading biopharma companies. Dr. Earl is a board member of several biotechnology companies and science-driven non-profit organizations. Most recently, Dr. Earl was the first President and CEO of BIO Ventures for Global Health (BVGH), a not-for-profit organization that engages the biotech industry in developing cures for infectious diseases of the least developed countries. At BVGH he defined an integral role for biotechnology sector in creating treatments for neglected tropical diseases, advocated new financial incentives for tropical disease R&D, and forged collaborations between leading companies and research institutions. Dr. Earl secured BVGH’s funding from foundations, corporations and individual donors, including the Bill & Melinda Gates Foundation. Previously, Dr. Earl served as Managing Director of Perseus Capital and the Perseus-Soros BioPharmaceutical Fund. Over eight years he led investments and served as a director on portfolio company boards. At Perseus and Perseus-Soros, Dr. Earl invested in companies that achieved FDA approval for multiple innovative drugs, particularly for the treatment of cancer. Earlier in his career, Dr. Earl was President and CEO of Avitech Diagnostics, Inc., and a General Partner of Plant Resources Venture Funds. Dr. Earl serves on the Board of Directors of Daktari Diagnostics, Inc. and Mirna Therapeutics, Inc. He is a Trustee of the Nature Conservancy of Maryland/DC and the Committee for Economic Development. Dr. Earl received a BA in Biology from the University of Pennsylvania, and a PhD in Cellular and Developmental Biology from Harvard University. "[1]
- Director, Asuragen
Resources and articles
Related Sourcewatch
References
- ↑ asuragen Christopher D. Earl, organizational web page, accessed November 5, 2019.
